ZENITH labs ltzen REPORT 4th QTR loss Zenith Laboratories company report fourth quarter loss amount determine completion year end audit company elaborate further quarter end Sept 30 1986 Zenith report loss 3451000 dlrs 16 ct share adjust 1986 2for1 stock split company receive Food Drug Administration approval market cefadroxil generic version antibiotic domestic sale exceed 50 mln dlrs 1986 Zenith market drug question relate applicability patent resolve